1. Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009

   • S. Lee
   • P. Glendenning
   • C. A. Inderjeeth

   Review 30 June 2010 Pages: 741 - 753

   

2. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review

   • K. Dusdal
   • J. Grundmanis
   • S. R. Harris

   Review 16 December 2010 Pages: 755 - 769

   

3. Development and validation of a disease model for postmenopausal osteoporosis

   • A. Gauthier
   • J. A. Kanis
   • On behalf of the Committee of Scientific Advisors, International Osteoporosis Foundation

   Original Article 11 August 2010 Pages: 771 - 780

   

4. Prevalent vertebral fractures predict subsequent radiographic vertebral fractures in postmenopausal Korean women receiving antiresorptive agent

   • S. H. Kim
   • H. S. Choi
   • S.-K. Lim

   Original Article 09 June 2010 Pages: 781 - 787

   

5. Fragility fractures and the osteoporosis care gap in women: the Canadian Multicentre Osteoporosis Study

   • L.-A. Fraser
   • G. Ioannidis
   • the CaMos Research Group

   Original Article 04 August 2010 Pages: 789 - 796

   

6. Change in hip fracture incidence over the last 6 years in France

   • M. Maravic
   • P. Taupin
   • C. Roux

   Original Article 02 June 2010 Pages: 797 - 801

   

7. Proximal hip geometry and hip fracture risk assessment in a Korean population

   • G. I. Im
   • M. J. Lim

   Original Article 15 June 2010 Pages: 803 - 807

   

8. Guidance for the adjustment of FRAX according to the dose of glucocorticoids

   • J. A. Kanis
   • H. Johansson
   • E. V. McCloskey

   Original Article 13 January 2011 Pages: 809 - 816

   

9. Construction of a FRAX^® model for the assessment of fracture probability in Canada and implications for treatment

   • W. D. Leslie
   • L. M. Lix
   • J. A. Kanis

   Original Article 16 December 2010 Pages: 817 - 827

   

10. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos

    • L.-A. Fraser
    • L. Langsetmo
    • CaMos Research Group

    Original Article 16 December 2010 Pages: 829 - 837

    

11. Spine–hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement

    • W. D. Leslie
    • L. M. Lix
    • J. A. Kanis

    Original Article 20 October 2010 Pages: 839 - 847

    

12. Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study

    • A. Lih
    • H. Nandapalan
    • M. J. Seibel

    Original Article 24 November 2010 Pages: 849 - 858

    

13. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis

    • K. A. Stockton
    • K. Mengersen
    • K. L. Bennell

    Original Article 06 October 2010 Pages: 859 - 871

    

14. Sunlight exposure or vitamin D supplementation for vitamin D-deficient non-western immigrants: a randomized clinical trial

    • I. S. Wicherts
    • A. J. P. Boeke
    • P. Lips

    Original Article Open access 04 August 2010 Pages: 873 - 882

    

15. Maternal vitamin D status affects bone growth in early childhood—a prospective cohort study

    • H. T. Viljakainen
    • T. Korhonen
    • C. Lamberg-Allardt

    Original Article Open access 10 December 2010 Pages: 883 - 891

    

16. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression

    • V. Rabenda
    • O. Bruyère
    • J.-Y. Reginster

    Original Article 09 November 2010 Pages: 893 - 901

    

17. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study

    • S. Pouwels
    • A. Lalmohamed
    • F. de Vries

    Original Article Open access 29 June 2010 Pages: 903 - 910

    

18. Polymorphisms in the 5′ flank of COL1A1 gene and osteoporosis: meta-analysis of published studies

    • H. Jin
    • E. Evangelou
    • S. H. Ralston

    Original Article 27 August 2010 Pages: 911 - 921

    

19. Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism

    • M. Kurajoh
    • M. Inaba
    • Y. Nishizawa

    Original Article 07 May 2010 Pages: 923 - 930

    

20. Bone quality is partially recovered after the discontinuation of RANKL administration in rats by increased bone mass on existing trabeculae: an in vivo micro-CT study

    • Graeme M. Campbell
    • Michael S. Ominsky
    • Steven K. Boyd

    Original Article 18 May 2010 Pages: 931 - 942

    

21. Adherence to osteoporosis drugs and fracture prevention: no evidence of healthy adherer bias in a frail cohort of seniors

    • S. M. Cadarette
    • D. H. Solomon
    • M. A. Brookhart

    Original Article 08 June 2010 Pages: 943 - 954

    

22. Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective

    • F. Borgström
    • O. Ström
    • J. A. Kanis

    Original Article 08 June 2010 Pages: 955 - 965

    

23. Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

    • B. Jönsson
    • O. Ström
    • J. A. Kanis

    Original Article 09 October 2010 Pages: 967 - 982

    

24. Oral bisphosphonates are associated with reduced mortality after hip fracture

    • L. A. Beaupre
    • D. W. Morrish
    • S. R. Majumdar

    Original Article 04 November 2010 Pages: 983 - 991

    

25. Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene

    • P. Vestergaard
    • F. Schwartz
    • L. Mosekilde

    Original Article 17 December 2010 Pages: 993 - 1001

    

26. Severe osteoporosis treated with teriparatide in a patient affected by recessive epidermolysis bullosa dystrophica

    • L. Moretti
    • A. Notarnicola
    • B. Moretti

    Case Report 11 May 2010 Pages: 1003 - 1006